adenovirus gene therapy Flt3L (Canji)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadenovirus gene therapy Flt3L (Canji)

Drug Alias NameAdv-Flt3L (Canji)adenovirus gene therapy Fms-like tyrosine kinase 3 ligand (Canji)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionTyrosine-protein kinase receptor FLT3 stimulants

TargetsTyrosine-protein kinase receptor FLT3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCanji Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCanji Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A